DTC Campaigns Blogs

09|25|25

Navigating the FDA’s DTC Crackdown: What Pharma Marketers Need to Know

The FDA’s recent wave of warning letters targeting direct-to-consumer (DTC) pharmaceutical advertising has sent ripples through the industry. While the agency’s actions may not make TV advertising impossible, they do signal a significant tightening of enforcement—particularly around the Clear, Conspicuous, and Neutral (CCN) standard. Read the blog to learn more.